Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease

Background/Hypothesis Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) tre...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cardiology (Mahwah, N.J.) N.J.), 2023-02, Vol.46 (2), p.223-231
Main Authors: Brockmeyer, Maximilian, Wies, Emilia, Joerges, Jamuna, Sommer, Jana, Borgmann, Sandra Olivia, Chernyak, Nadja, Lin, Yingfeng, Parco, Claudio, Schulze, Volker, Heinen, Yvonne, Kelm, Malte, Icks, Andrea, Perings, Stefan, Wolff, Georg
Format: Article
Language:English
Subjects:
Analysis
Atherosclerosis
Cardiac patients
Cardiology
Cardiovascular disease
Cardiovascular Diseases
Care and treatment
Cholesterol
Cholesterol, LDL
Chronic illnesses
Clinical Trial Result
Clinical trials
Coronary heart disease
Decision making
Diabetes
Diabetes Mellitus
Diabetes therapy
Disease prevention
Dyslipidemias - diagnosis
Dyslipidemias - drug therapy
Dyslipidemias - epidemiology
Education
Female
glycated
Glycated Hemoglobin
Glycosylated hemoglobin
Goals
hemoglobin (HbA1c)
Hospitalization
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertension
information needs
Information sources
Kidney diseases
Knowledge
Lipids
Low density lipoproteins
low‐density lipoprotein cholesterol (LDL cholesterol)
Male
Metabolic disorders
patient information
patient knowledge
Patients
Physicians
Preferences
Questionnaires
Risk Factors
treatment goals
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Hypothesis Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) treatment goals, subjective level of information, and information needs in very high‐risk patients with ASCVD. Methods ASCVD patients (n = 210; 75 ± 9 years; 71.4% male; 89.5% coronary disease) with DM (96.7% type 2) completed a questionnaire assessing knowledge of HbA1c and LDL‐C treatment goals and subjective level of information and information needs on disease‐related topics of DM and ASCVD. Serum LDL‐C and HbA1c were measured. Results HbA1c goal (
ISSN:0160-9289
1932-8737
DOI:10.1002/clc.23948